CytRx’s Bafetinib Demonstrates Ability to Prevent Cancer-Related Bone Loss

		Cancer Friends Network > Types of Cancer > Bone Cancer
CytRx’s Bafetinib Demonstrates Ability to Prevent Cancer-Related Bone Loss

LinkBack

Thread Tools

Display Modes

#1 (permalink)

02-17-2011, 10:20 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,337

CytRx’s Bafetinib Demonstrates Ability to Prevent Cancer-Related Bone Loss

CytRx Corporation , a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies show that bafetinib may be useful in preventing bone loss in cancer patients who are at high risk for this event.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 06:48 PM.

CancerFriends.net